Matthew Harrison
Stock Analyst at Morgan Stanley
(3.38)
# 905
Out of 4,905 analysts
706
Total ratings
48.12%
Success rate
2.7%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Overweight | $102 → $108 | $102.56 | +5.31% | 18 | Jul 17, 2025 | |
| R Ryder System | Initiates: Positive | $215 | $169.90 | +26.55% | 1 | Jul 15, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $755 → $754 | $542.52 | +38.98% | 54 | Jul 10, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $80 → $81 | $41.59 | +94.76% | 12 | Jul 10, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $464 → $460 | $459.81 | +0.04% | 40 | Jun 20, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Equal-Weight | $113 → $40 | $14.08 | +184.19% | 37 | Jun 17, 2025 | |
| GILD Gilead Sciences | Maintains: Overweight | $130 → $135 | $108.22 | +24.75% | 42 | Apr 25, 2025 | |
| AVIR Atea Pharmaceuticals | Maintains: Equal-Weight | $6.2 → $6 | $3.36 | +78.57% | 10 | Apr 11, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $157 → $152 | $124.99 | +21.61% | 53 | Apr 9, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $39 → $32 | $31.26 | +2.37% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $0.88 | +470.06% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $41 → $33 | $14.00 | +135.71% | 12 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $150.49 | +18.28% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $32.50 | +72.31% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $34.54 | +59.24% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.59 | +88.68% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $4 → $6 | $2.05 | +192.68% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $15.69 | -29.89% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $1.41 | +467.38% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $510 | $564.59 | -9.67% | 24 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.76 | +153.62% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $112 | $57.29 | +95.50% | 21 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $23.01 | +47.76% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $21.88 | +46.25% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $4.13 | +360.05% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $13 | $8.07 | +61.09% | 4 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.75 | +33.78% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $19.58 | -48.91% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $7.65 | +4.64% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $31.17 | +41.16% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $4.63 | +180.78% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $9.24 | +765.80% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $5.53 | +984.99% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $110.02 | +96.33% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $3.03 | +65.02% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.75 | +185.71% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $189.26 | -3.84% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $5.52 | +63.04% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $52.08 | -23.20% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $294.76 | -4.33% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $320.53 | -34.48% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $24.47 | +112.51% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $163.70 | +5.68% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $61 → $57 | $9.12 | +525.34% | 9 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $26.31 | +356.10% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $14.05 | +953.38% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $79.96 | +2.55% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $47.36 | +39.36% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $2.57 | +1,417.51% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $35.59 | +29.25% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $9.46 | +269.98% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $771.71 | -64.36% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.08 | +813.46% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $8.16 | +659.80% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $16.71 | +3.23% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $50 | $0.10 | +48,209.18% | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $67.86 | +22.31% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $37.23 | -73.14% | 4 | Sep 10, 2018 |
Insmed
Jul 17, 2025
Maintains: Overweight
Price Target: $102 → $108
Current: $102.56
Upside: +5.31%
Ryder System
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $169.90
Upside: +26.55%
Regeneron Pharmaceuticals
Jul 10, 2025
Maintains: Overweight
Price Target: $755 → $754
Current: $542.52
Upside: +38.98%
Legend Biotech
Jul 10, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $41.59
Upside: +94.76%
Vertex Pharmaceuticals
Jun 20, 2025
Maintains: Equal-Weight
Price Target: $464 → $460
Current: $459.81
Upside: +0.04%
Sarepta Therapeutics
Jun 17, 2025
Downgrades: Equal-Weight
Price Target: $113 → $40
Current: $14.08
Upside: +184.19%
Gilead Sciences
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $108.22
Upside: +24.75%
Atea Pharmaceuticals
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $3.36
Upside: +78.57%
Biogen
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $157 → $152
Current: $124.99
Upside: +21.61%
Moderna
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $39 → $32
Current: $31.26
Upside: +2.37%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.88
Upside: +470.06%
Mar 7, 2025
Assumes: Overweight
Price Target: $41 → $33
Current: $14.00
Upside: +135.71%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $150.49
Upside: +18.28%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $32.50
Upside: +72.31%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $34.54
Upside: +59.24%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.59
Upside: +88.68%
Sep 16, 2024
Maintains: Overweight
Price Target: $4 → $6
Current: $2.05
Upside: +192.68%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $15.69
Upside: -29.89%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $1.41
Upside: +467.38%
May 28, 2024
Maintains: Overweight
Price Target: $515 → $510
Current: $564.59
Upside: -9.67%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.76
Upside: +153.62%
Apr 26, 2024
Maintains: Overweight
Price Target: $115 → $112
Current: $57.29
Upside: +95.50%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $23.01
Upside: +47.76%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $21.88
Upside: +46.25%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $4.13
Upside: +360.05%
Mar 27, 2023
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $8.07
Upside: +61.09%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.75
Upside: +33.78%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $19.58
Upside: -48.91%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $7.65
Upside: +4.64%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $31.17
Upside: +41.16%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $4.63
Upside: +180.78%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $9.24
Upside: +765.80%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $5.53
Upside: +984.99%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $110.02
Upside: +96.33%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.03
Upside: +65.02%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.75
Upside: +185.71%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $189.26
Upside: -3.84%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $5.52
Upside: +63.04%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $52.08
Upside: -23.20%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $294.76
Upside: -4.33%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $320.53
Upside: -34.48%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $24.47
Upside: +112.51%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $163.70
Upside: +5.68%
Mar 10, 2022
Maintains: Equal-Weight
Price Target: $61 → $57
Current: $9.12
Upside: +525.34%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $26.31
Upside: +356.10%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $14.05
Upside: +953.38%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $79.96
Upside: +2.55%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $47.36
Upside: +39.36%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $2.57
Upside: +1,417.51%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $35.59
Upside: +29.25%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $9.46
Upside: +269.98%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $771.71
Upside: -64.36%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.08
Upside: +813.46%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $8.16
Upside: +659.80%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $16.71
Upside: +3.23%
Aug 18, 2020
Downgrades: Equal-Weight
Price Target: $50
Current: $0.10
Upside: +48,209.18%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $67.86
Upside: +22.31%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $37.23
Upside: -73.14%